test

Scott Epstein

@Avoro Capital Advisors Llc

Latest period2024 - Q3ReportedManaged Assets$6.858BTotal holdings36
Assets growth rate-8.66%Assets growth rate (2-Q avg)-10.54%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Avoro Capital Advisors Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.

Assets under management

The assets under management (AUM) of Avoro Capital Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.858B in assets, with a quarterly growth rate of -8.66% and a 2-quarter average growth rate of -10.54%. The portfolio is managed by Scott Epstein, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
OCULOcular Therapeutix Inc
Recent Activity
1.03%
$70.122M
8.06M shares@ $8.7 avg price
KURAKura Oncology Inc
Recent Activity
1.01%
$69.201M
3.542M shares@ $19.55 avg price
MRUSMerus N V
Recent Activity
0.99%
$67.696M
1.355M shares@ $49.96 avg price
TRMLTourmaline Bio Inc
Recent Activity
0.84%
$57.133M
2.222M shares@ $25.72 avg price
MNKDMannkind Corp
Recent Activity
Decreased -0.1%
0.81%
$55.038M
8.75M shares@ $6.29 avg price
RAREUltragenyx Pharmaceutical Inc
Recent Activity
0.68%
$46.106M
830,000 shares@ $55.55 avg price
AUTLAutolus Therapeutics Plc
Recent Activity
0.66%
$44.815M
12.346M shares@ $3.63 avg price
IOVAIovance Biotherapeutics Inc
Recent Activity
Decreased -63.76%
0.59%
$39.814M
4.24M shares@ $9.39 avg price
TSHATaysha Gene Therapies Inc
Recent Activity
0.55%
$37.486M
18.65M shares@ $2.01 avg price
GLUEMonte Rosa Therapeutics Inc
Recent Activity
Increased 27.68%
0.45%
$30.688M
5.79M shares@ $5.31 avg price